Company Filing History:
Years Active: 2002-2016
Title: Innovator Yves Cordier: Pioneering Research in Poxvirus Production
Introduction
Yves Cordier, an accomplished inventor based in Strasbourg, France, has made significant strides in the field of virology. With a total of eight patents to his name, Cordier's work primarily focuses on producing and purifying poxviruses, contributing to advancements in medicinal compositions and therapeutic applications.
Latest Patents
Cordier's latest inventions include two notable patents:
1. **Process for Producing Poxviruses and Poxvirus Compositions** - This invention outlines compositions and pharmaceutical formulations comprising poxviruses, specifically extracellular enveloped viruses. It details a process for generating poxviruses and highlights their potential use in preparing medicaments.
2. **Method for Orthopoxvirus Production and Purification** - In this patent, Cordier describes a method for producing and purifying various forms of Orthopoxviruses, including wild type, attenuated, and recombinant strains. The purified viruses can be utilized in pharmaceutical compositions, particularly vaccines, for treating and preventing cancers, infectious diseases, and autoimmune disorders. His method also incorporates the use of a specific immortalized avian cell line for enhanced virus production.
Career Highlights
Yves Cordier has dedicated his career to virology and innovation in therapeutic approaches. His patents not only reflect his technical expertise but also his commitment to developing practical applications that could benefit public health and advance scientific knowledge in the treatment of serious diseases.
Collaborations
Throughout his career, Cordier has collaborated with notable professionals in his field, including Claude Sene and Daniel Malarme. These collaborations have fostered an environment of innovation and have been crucial in the successful development and patenting of his research initiatives.
Conclusion
Yves Cordier's contributions to the scientific community, particularly in the area of poxvirus research, underscore his role as a leading inventor. His ongoing work at Transgene S.A. continues to pave the way for innovative solutions in medicine and virology, showcasing the importance of persistent research and invention in addressing global health challenges.